anti-C1QTNF9 antibody product blog
Tags: Antibody; Polyclonal Antibody; C1QTNF9; CTRP9; anti-C1QTNF9 antibody;
The C1QTNF9 c1qtnf9 (Catalog #MBS648585) is an Antibody produced from Guinea pig and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s CTRP9 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA, Western Blot. Researchers should empirically determine the suitability of the C1QTNF9 c1qtnf9 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The C1QTNF9 c1qtnf9 product has the following accession number(s) (GI #65301115) (NCBI Accession #NP_848635.2) (Uniprot Accession #P0C862). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
CTRP9 belongs to a highly conserved family of adiponectin paralogs. It activates AMPK, AKT and p44/42 MAPK signaling pathways. Expressed predominantly in adipose tissue. Females express higher levels than males. Overexpression of CTRP9 in obese (ob/ob) mice significantly lowered serum glucose levels.
Immunogen: Recombinant human CTRP9. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing C1QTNF9 are readily searchable from our website. Different antibodies against the same target such as C1QTNF9 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Inflammation are some of the diseases may be linked to CTRP9 (Complement C1q Tumor Necrosis Factor-related Protein 9, C1QTNF9, C1qTNF-related Protein 9).